Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progenitor renewal associated non-coding RNA (PRANCR) is a long non-coding RNA (lncRNA) known to regulate progenitor cell renewal and differentiation. It is transcribed near the coding gene CNOT2 (CCR4-NOT complex subunit 2) but does not code for protein. PRANCR modulates transcriptional programs, influencing cell fate decisions in tissues such as skin, and is studied for its role in cell proliferation and possible cancer-related processes. Its functional mechanisms involve non-coding RNA regulation of gene expression, often in coordination with chromatin modifiers or transcriptional regulators. PRANCR is referenced in genome databases (HGNC:51126) and is a focus of ongoing basic research in developmental biology and cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Progenitor renewal associated non-coding RNA (PRANCR).